Non-alcoholic steatohepatitis is a risk factor for intrahepatic cholangiocarcinoma and affects its long-time outcome: results from a multicenter international case-control study

Stefania De Lorenzo(Azienda USL di Bologna), Giovanni Brandi(Hôpital Beaujon), Karim Boudjéma(Inserm), Deborah Malvi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Bruno Turlin(Inserm), Francesco Vasuri(Ospedale "Santa Maria delle Croci" di Ravenna), Astrid Lièvre(Inserm), Maria Antonietta D’Errico, Alessandro Mazzotta(Inserm), Francesco Tovoli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Journal of Hepatology
August 1, 2020
10.1016/s0168-8278(20)31272-1
Cited by 0

Related Papers

A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
|Journal of Biological Chemistry|2001|1.7k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|1.1k
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
|˜The œLancet. Gastroenterology & hepatology|2020|602
Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture.
|Molecular Pharmacology|1993|536
Insulin resistance–associated hepatic iron overload
|Gastroenterology|1999|509